Linda Fried, MD, MPH, FASN, is Professor of Medicine, Epidemiology, and Clinical & Translational Science at the University of Pittsburgh and a Staff Physician at the VA Pittsburgh Healthcare System.

She earned her medical degree from the Mount Sinai School of Medicine in New York and completed an internal medicine residency at Columbia Presbyterian Medical Center, followed by a fellowship in nephrology at the University of Pittsburgh Medical Center. She also holds a Master of Public Health degree from the University of Pittsburgh.

Dr. Fried's research interests focus on the progression of and risk factors for chronic kidney disease and how they pertain to mortality and cardiovascular disease and aging-related outcomes in CKD. She is active in both epidemiologic studies and clinical trials, especially for diabetic kidney disease. She chaired the VA NEPHRON D study, which assessed combination ACEI and ARB therapy in diabetic kidney disease. She is part of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Study, as co-PI of the coordinating center. This study aims to reduce adverse outcomes and CKD in patients discharged from hospital after AKI.

Highly active as a committee member and advisor, Dr. Fried has served on the FDA Cardiovascular and Renal Drug Advisory Committee and several expert panels for the National Institute of Diabetes and Digestive and Kidney Diseases. She is currently an ASN Councilor